459 related articles for article (PubMed ID: 15087599)
1. The hemostatic defect of cardiopulmonary bypass.
Linden MD
J Thromb Thrombolysis; 2003 Dec; 16(3):129-47. PubMed ID: 15087599
[TBL] [Abstract][Full Text] [Related]
2. Alterations of hemostasis associated with cardiopulmonary bypass: pathophysiology, prevention, diagnosis, and management.
Bick RL
Semin Thromb Hemost; 1976 Oct; 3(2):59-82. PubMed ID: 798278
[TBL] [Abstract][Full Text] [Related]
3. Activation of the hemostatic system during cardiopulmonary bypass.
Sniecinski RM; Chandler WL
Anesth Analg; 2011 Dec; 113(6):1319-33. PubMed ID: 22003219
[TBL] [Abstract][Full Text] [Related]
4. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
5. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
6. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass.
Chandler WL
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):459-67. PubMed ID: 16085250
[TBL] [Abstract][Full Text] [Related]
7. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass.
Khuri SF; Valeri CR; Loscalzo J; Weinstein MJ; Birjiniuk V; Healey NA; MacGregor H; Doursounian M; Zolkewitz MA
Ann Thorac Surg; 1995 Oct; 60(4):1008-14. PubMed ID: 7574939
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation.
Fang ZA; Navaei AH; Hensch L; Hui SR; Teruya J
Semin Thromb Hemost; 2020 Feb; 46(1):62-72. PubMed ID: 31858515
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced platelet dysfunction and cardiopulmonary bypass.
Muriithi EW; Belcher PR; Day SP; Menys VC; Wheatley DJ
Ann Thorac Surg; 2000 Jun; 69(6):1827-32. PubMed ID: 10892931
[TBL] [Abstract][Full Text] [Related]
10. Minimizing intraoperative hemodilution by use of a very low priming volume cardiopulmonary bypass in neonates with transposition of the great arteries.
Redlin M; Huebler M; Boettcher W; Kukucka M; Schoenfeld H; Hetzer R; Habazettl H
J Thorac Cardiovasc Surg; 2011 Oct; 142(4):875-81. PubMed ID: 21570096
[TBL] [Abstract][Full Text] [Related]
11. [Hemostatic changes in extracorporeal surgery: pathogenesis and treatment].
Páramo JA; Rifón J; Rocha E
Sangre (Barc); 1993 Jun; 38(3):225-31. PubMed ID: 8211549
[No Abstract] [Full Text] [Related]
12. Beneficial effects of mini-cardiopulmonary bypass on hemostasis in coronary artery bypass grafting: analysis of inflammatory response and hemodilution.
Ohata T; Mitsuno M; Yamamura M; Tanaka H; Kobayashi Y; Ryomoto M; Yoshioka Y; Tsujiya N; Miyamoto Y
ASAIO J; 2008; 54(2):207-9. PubMed ID: 18356657
[TBL] [Abstract][Full Text] [Related]
13. Coagulation disorders of cardiopulmonary bypass: a review.
Paparella D; Brister SJ; Buchanan MR
Intensive Care Med; 2004 Oct; 30(10):1873-81. PubMed ID: 15278267
[TBL] [Abstract][Full Text] [Related]
14. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
15. Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study.
Vedin J; Antovic A; Ericsson A; Vaage J
Ann Thorac Surg; 2005 Aug; 80(2):586-93. PubMed ID: 16039210
[TBL] [Abstract][Full Text] [Related]
16. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
17. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements.
Rosengart TK; DeBois W; O'Hara M; Helm R; Gomez M; Lang SJ; Altorki N; Ko W; Hartman GS; Isom OW; Krieger KH
J Thorac Cardiovasc Surg; 1998 Feb; 115(2):426-38; discussion 438-9. PubMed ID: 9475538
[TBL] [Abstract][Full Text] [Related]
18. Preventive Strategies for Minimizing Hemodilution in the Cardiac Surgery Patient During Cardiopulmonary Bypass.
Hwang NC
J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1663-71. PubMed ID: 26520025
[No Abstract] [Full Text] [Related]
19. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
[TBL] [Abstract][Full Text] [Related]
20. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
